|
US6605642B2
(en)
|
1999-04-05 |
2003-08-12 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGES)
|
|
US7030133B2
(en)
*
|
1999-04-05 |
2006-04-18 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGEs)
|
|
DE60008509T2
(de)
*
|
1999-04-05 |
2004-12-16 |
City Of Hope, Duarte |
Neue Hemmer von fortgeschrittenen Glykosilierungsendprodukten (AGEs)
|
|
US6262118B1
(en)
*
|
1999-06-04 |
2001-07-17 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
|
|
US7576131B2
(en)
|
1999-06-04 |
2009-08-18 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
|
|
WO2001035976A1
(en)
*
|
1999-11-18 |
2001-05-25 |
Bolla John D |
Treatment or prevention of photoaging and skin cancer
|
|
US7199259B2
(en)
*
|
2003-06-20 |
2007-04-03 |
Metabolex, Inc. |
Resolution of α-(phenoxy)phenylacetic acid derivatives
|
|
CA2543611A1
(en)
|
2003-10-27 |
2005-05-19 |
City Of Hope |
Methods of lowering lipid levels in a mammal
|
|
EP1751120A4
(en)
*
|
2004-05-25 |
2010-05-05 |
Metabolex Inc |
SUBSTITUTED TRIAZOLE AS PPAR MODULATORS AND MANUFACTURING METHOD THEREFOR
|
|
WO2005115384A2
(en)
*
|
2004-05-25 |
2005-12-08 |
Metabolex, Inc. |
Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
|
|
US7399493B2
(en)
*
|
2004-07-16 |
2008-07-15 |
Wille John J |
Anti-irritant botanicals
|
|
CA2580329C
(en)
|
2004-09-13 |
2015-01-06 |
Chrono Therapeutics Inc. |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
US20070042026A1
(en)
*
|
2005-03-17 |
2007-02-22 |
Wille John J |
Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
|
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
|
US7714131B2
(en)
*
|
2005-09-23 |
2010-05-11 |
Metabolex, Inc. |
Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
|
|
EP2729148A4
(en)
|
2011-07-06 |
2015-04-22 |
Parkinson S Inst |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
EP3250258A4
(en)
|
2015-01-28 |
2018-09-05 |
Chrono Therapeutics, Inc. |
Drug delivery methods and systems
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
AU2018205529B2
(en)
|
2017-01-06 |
2023-08-10 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
MA54245A
(fr)
|
2018-11-16 |
2022-02-23 |
Morningside Venture Investments Ltd |
Système d'administration transdermique de médicaments à régulation thermique
|
|
US11865602B2
(en)
*
|
2020-01-16 |
2024-01-09 |
Ehc Inc. |
Paintless dent removal tool, system and method
|